This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Vivus Announces 2012 Medical Societal Meeting Schedule For Qsymia (Phentermine And Topiramate Extended-Release) CIV

Stocks in this article: VVUS

MOUNTAIN VIEW, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the Qsymia™ medical societal meeting schedule upcoming in 2012. The VIVUS presence and Qsymia awareness at these key meetings include scientific presentations, continuing medical education or CME support and/or promotional product theater.

"The Qsymia Fall schedule will build on the success from The Obesity Society (TOS) meeting recently held in San Antonio. The Qsymia launch coincided with TOS and the response from the attendees was positive.  Qsymia was featured in several presentations, and traffic through the exhibit booth was very high," stated Michael Miller, SVP and Chief Commercial Officer of VIVUS. "Healthcare provider education and awareness of Qsymia are areas of primary focus during this initial launch period. Our participation in these upcoming medical meetings will further this cause beyond the obesity specialists." 

Upcoming conference schedule:

Conference  Dates Location
Academy of Managed Care Pharmacies Oct. 3-5, 2012 Cincinnati
American College of Nurse Practitioners Oct. 3-7, 2012 Toronto
7 th Annual Obesity Summit
(Cleveland Clinic) Oct. 4-5, 2012 Cleveland
Osteopathic Medical Conference &
Exposition Oct 7-11, 2012 San Diego
Cardiometabolic Health Congress Oct. 10-13, 2012 Boston
American Academy of Family Physicians Oct. 16-20, 2012 Philadelphia
American Society of Bariatric Physicians Oct. 24-28, 2012 Orlando
Obesity Action Coalition Oct. 25-28, 2012 Dallas
American Heart Association Nov. 3-7, 2012 Los Angeles

Qsymia is available only through certified mail order pharmacies that are part of the Qsymia Home Delivery Network, including CVS Pharmacy and Walgreens.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs